Literature DB >> 33026050

Risk factors for hospital admission among COVID-19 patients with diabetes. A study from Saudi Arabia.

Ayman A Al Hayek1, Asirvatham A Robert, Abdullah Bin Matar, Ali Algarni, Haneen Alkubedan, Turki Alharbi, Afrah Al Amro, Seham A Alrashidi, Mohamed Al Dawish.   

Abstract

OBJECTIVES: To elucidate the risk factors for hospital admission among COVID-19 patients with type 2 diabetes mellitus (T2DM).
METHODS: This retrospective study was conducted at the Prince Sultan Military Medical City, Riyadh, Saudi Arabia between May 2020 and July 2020. Out of 7,260 COVID-19 patients, 920 were identified as T2DM. After the exclusion process, 806 patients with T2DM were included in this analysis. Patients' data were extracted from electronic medical records. A logistic regression model was performed to estimate the risk factors of hospital admission. 
Results: Of the total of 806 COVID-19 patients with T2DM, 48% were admitted in the hospital, 52% were placed under home isolation. Older age between 70-79 years (OR [odd ratio] 2.56; p=0.017), ≥80 years (OR 6.48; p=0.001) were significantly more likely to be hospitalized compared to less than 40 years. Similarly, patients with higher HbA1c level of ≥9% compared to less than 7%; (OR 1.58; p=0.047); patients with comorbidities such as, hypertension (OR 1.43; p=0.048), cardiovascular disease (OR 1.56; p=0.033), cerebrovascular disease (OR 2.38; p=0.016), chronic pulmonary disease (OR 1.51; p=0.018), malignancy (OR 2.45; p=0.025), chronic kidney disease (CKD) IIIa, IIIb, IV (OR 2.37; p=0.008), CKD V (OR 5.07; p=0.007) were significantly more likely to be hospitalized. Likewise, insulin-treated (OR 1.46; p=0.03) were more likely to require hospital admission compared to non-insulin treated patients.
CONCLUSION: Among COVID-19 patients with diabetes, higher age, high HbA1c level, and presence of other comorbidities were found to be significant risk factors for the hospital admission.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33026050     DOI: 10.15537/smj.2020.10.25419

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  9 in total

Review 1.  Potential role of biochemical markers in the prognosis of COVID-19 patients.

Authors:  Apeksha Niraula; Nirmal Baral; Madhab Lamsal; Mahima Bataju; Saroj Thapa
Journal:  SAGE Open Med       Date:  2022-07-05

2.  Hospitalization and mortality from COVID-19 of patients with rheumatic inflammatory diseases in Andalusia.

Authors:  Natalia Mena-Vázquez; Sara Manrique Arija; Marta Rojas-Giménez; Enrique Raya-Ÿlvarez; María Luisa Velloso-Feijoó; C López-Medina; Consuelo Ramos-Giraldez; Francisco Javier Godoy-Navarrete; Rocío Redondo-Rodríguez; Alba María Cabezas-Lucena; M Morales-Ÿguila; C M Romero-Barco; Antonio Fernández-Nebro
Journal:  Reumatol Clin (Engl Ed)       Date:  2021-09-09

Review 3.  COVID-19 endocrinopathy with hindsight from SARS.

Authors:  Narasimhan Kothandaraman; Anantharaj Rengaraj; Bo Xue; Wen Shan Yew; S Sendhil Velan; Neerja Karnani; Melvin Khee Shing Leow
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-11-25       Impact factor: 4.310

4.  Hospitalization and Mortality from COVID-19 of Patients with Rheumatic Inflammatory Diseases in Andalusia.

Authors:  Natalia Mena-Vázquez; Sara Manrique Arija; Marta Rojas-Giménez; Enrique Raya-Álvarez; María Luisa Velloso-Feijoó; C López-Medina; Consuelo Ramos-Giraldez; Francisco Javier Godoy-Navarrete; Rocío Redondo-Rodríguez; Alba María Cabezas-Lucena; M Morales-Águila; C M Romero-Barco; Antonio Fernández-Nebro
Journal:  Reumatol Clin (Engl Ed)       Date:  2021-03-20

Review 5.  Diabetes and COVID-19.

Authors:  Zohair Jamil Gazzaz
Journal:  Open Life Sci       Date:  2021-03-25       Impact factor: 0.938

6.  Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia.

Authors:  Manal Faleh AlMutairi; Ayla M Tourkmani; Alian A Alrasheedy; Turki J ALHarbi; Abdulaziz M Bin Rsheed; Mohammed ALjehani; Yazed AlRuthia
Journal:  Ther Adv Chronic Dis       Date:  2021-09-08       Impact factor: 5.091

7.  Baseline haemoglobin A1c and the risk of COVID-19 hospitalization among patients with diabetes in the INSIGHT Clinical Research Network.

Authors:  Jea Young Min; Nicholas Williams; Will Simmons; Samprit Banerjee; Fei Wang; Yongkang Zhang; April B Reese; Alvin I Mushlin; James H Flory
Journal:  Diabet Med       Date:  2022-02-28       Impact factor: 4.213

Review 8.  Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.

Authors:  Iman Dandachi; Waleed Aljabr
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

Review 9.  Root Causes of Fungal Coinfections in COVID-19 Infected Patients.

Authors:  Arman Amin; Artin Vartanian; Nicole Poladian; Alexander Voloshko; Aram Yegiazaryan; Abdul Latif Al-Kassir; Vishwanath Venketaraman
Journal:  Infect Dis Rep       Date:  2021-12-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.